Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07048574 · ClinicalTrials.gov registry record

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

A clinical trial of Cystic Fibrosis (CF), sponsored by State University of New York at Buffalo.

Recruiting
Registry status
600
Enrollment target
13
Study locations

NCT07048574 is a study of Cystic Fibrosis (CF) that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 600 participants, above the 98-participant average among 14 other Cystic Fibrosis (CF) trials with a reported enrollment target (512% higher). The trial reports 13 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07048574, a study of Cystic Fibrosis (CF), is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
600 participants
Enrollment target
13
Study locations

Study Summary

This is a longitudinal, observational epidemiological study designed to estimate the prevalence of depression, anxiety, and behavior problems in children ages 18 months through 11 years with cystic fibrosis (CF).

Conditions Studied

Study Locations (13)

Florida

  • Joe DiMaggio - Hollywood
  • Nemours Foundation - Orlando

California

  • Children's Hospital of Orange County - Orange

Colorado

  • Children's Hospital Colorado - Aurora

Indiana

  • Indiana University - Bloomington

Massachusetts

  • Massachusetts General Hospital - Boston

New York

  • University at Buffalo - Buffalo

North Carolina

  • University of North Carolina School of Medicine - Chapel Hill

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2025-06-02
Est. Completion 2028-06-30

What the Registry Record Tells You About NCT07048574

The ClinicalTrials.gov registry entry for NCT07048574 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 98-participant average among 14 other Cystic Fibrosis (CF) trials with a reported enrollment target (512% higher). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cystic Fibrosis (CF) appearing as the primary indexed condition, and to 0 interventions.

NCT07048574 reports 13 study locations spanning 12 distinct geographic areas - top geographies include Florida, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT07048574 about?

NCT07048574 is a clinical study titled "TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age". This is a longitudinal, observational epidemiological study designed to estimate the prevalence of depression, anxiety, and behavior problems in children ages 18 months through 11 years with cystic fibrosis (CF).

What is the current status of trial NCT07048574?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2025-06-02. Estimated completion is 2028-06-30.

What conditions does trial NCT07048574 study?

This clinical trial studies the following conditions: Cystic Fibrosis (CF).

Who is sponsoring clinical trial NCT07048574?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07048574 being conducted?

This trial has 13 study locations across California, Colorado, Florida, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cystic Fibrosis (CF)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.